monarchE vs. PALLAS Data on Adjuvant ET in HR+ EBC: What Makes the Clinical Difference Between CDK4/6 Inhibitors Abemaciclib & Palbociclib?
By
CECOG Academy
FEATURING
Ahmad Awada
By
CECOG Academy
FEATURING
Ahmad Awada
This video was completed prior to Abemaciclib receiving FDA approval on 10/12/21
Comments 0
Login to view comments.
Click here to Login
